← Browse by Condition
Medical Condition
antiphospholipid syndrome aps
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for antiphospholipid syndrome aps sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1 2
Phase 2 1
Top Sponsors
2 trials
1 trial
NCT06747312 Phase 2
Recruiting
Effect of Belimumab on Antibody Titers in Primary APS Patients
Enrollment
20 pts
Location
China
Sponsor
Ruijin Hospital
NCT06978647 Phase 1
Recruiting
A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
Enrollment
12 pts
Location
China
Sponsor
China Immunotech (Beijing) Bio...
NCT07104721 Phase 1
Recruiting
A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Enrollment
18 pts
Location
China
Sponsor
China Immunotech (Beijing) Bio...